Pérez A, Ledea N, Hermández K, Garcia-Barreto D
Pol J Pharmacol Pharm. 1977 Sep-Oct;29(5):527-32.
With the purpose of estimating quantitative differences between disopyramide and quinidine two experimental series were designed. In order to establish the atropinic potency of both drugs, pA2 values were determined in rabbits right atria, using acetylcholine as agonist. The capacity to prevent ventricular fibrillation in albino mice subjected to chloroform apnea was also tested using various doses of the drugs. An effective median dose (ED50) to each of the drugs was calculated and the relative antiarrhythmic potency was compared. Disopyramide showed in both experimental series to be a more potent agent than quinidine.
为了评估丙吡胺和奎尼丁之间的定量差异,设计了两个实验系列。为了确定两种药物的阿托品样效力,以乙酰胆碱为激动剂,在兔右心房中测定pA2值。还使用不同剂量的药物测试了其预防接受氯仿窒息的白化小鼠心室颤动的能力。计算了每种药物的有效中剂量(ED50),并比较了相对抗心律失常效力。在两个实验系列中,丙吡胺均显示出比奎尼丁更有效的药物。